Manhattan Pharmaceuticals Reports Results for Six Months Ended June 30, 2006 and Reduced Loss for the Three Months Ended March 3, 2006
August 14, 2006 08:30 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 14, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced financial results for the six months ended June 30, 2006. Net loss for the period was approximately...
Manhattan Pharmaceuticals to Present at 2nd Annual Obesity Drug Development Summit
July 19, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, chief medical officer, will present a scientific overview of oral...
Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer
July 10, 2006 10:21 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Michael G. McGuinness joined the company as Chief Financial Officer, effective today. Mr....
Manhattan Pharmaceuticals to Present at CE Unterberg Towbin Emerging Growth Conference
July 05, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, July 5, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Ring Opening Bell At American Stock Exchange
June 07, 2006 10:09 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, June 7, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer, will ring the opening bell at the American...
Manhattan Pharmaceuticals to Present at Pacific Growth Equities Life Sciences Growth Conference
June 06, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, June 6, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Present at Friedman Billings Ramsey 2006 Growth Investor Conference
May 24, 2006 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 24, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference, May 15-16, Monaco
May 10, 2006 10:22 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 10, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Douglas Abel, president and chief executive officer of Manhattan Pharmaceuticals, Inc. will be...
Manhattan Pharmaceuticals Invited to Participate in Three Scientific Meetings On Obesity and Related Disorders
May 08, 2006 11:21 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, May 8, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced today it has accepted invitations to participate in three upcoming scientific meetings focused on obesity and...
Manhattan Pharmaceuticals Reports Update on Clinical Development Programs
April 28, 2006 16:10 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, April 28, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) announced the following update regarding the development status of oral Oleoyl-estrone for obesity and topical PTH...